TY - JOUR
T1 - Characteristics for Medical Cannabis Treatment Adherence among Autistic Children and Their Families
T2 - A Mixed-Methods Analysis
AU - David, Ayelet
AU - Stolar, Orit
AU - Berkovitch, Matitiahu
AU - Kohn, Elkana
AU - Waisman-Nitzan, Michal
AU - Hartmann, Inbar
AU - Gal, Eynat
N1 - Publisher Copyright:
© 2024 The Author(s). Published by S. Karger AG, Basel.
PY - 2024/4/16
Y1 - 2024/4/16
N2 - Introduction: Medical cannabis treatment for autistic children has recently become popular, and studies have focused on examining the treatment's effects on children's symptom presentation, reported side effects, and dropout rates. However, no previous study has investigated the factors influencing adherence and dropout rates in cannabis treatment. Method: This explanatory sequential mixedmethods study explored these factors by examining the characteristics of 87 autistic children and their families and deepening parents' perspectives and experiences of the 6- month CBD-rich cannabis treatment's benefits and barriers. Results: We found this treatment to have a high (75%) adherence rate, relatively mild side effects, and substantial reported benefits for the children and families. However, this treatment was not free of barriers; the intake regime, some side effects, and in some cases, unrealistic parental expectations made adherence difficult for some families. Conclusion: Our results highlight the importance of providing professional guidance and knowledge to parents of autistic children, enhancing their understanding of the impact of CBD-rich cannabis treatment on their children and expected related challenges, and coordinating realistic treatment expectations. We hope that addressing these important aspects will influence parents' ability to adhere to and enjoy the benefits of cannabis treatment for their autistic children.
AB - Introduction: Medical cannabis treatment for autistic children has recently become popular, and studies have focused on examining the treatment's effects on children's symptom presentation, reported side effects, and dropout rates. However, no previous study has investigated the factors influencing adherence and dropout rates in cannabis treatment. Method: This explanatory sequential mixedmethods study explored these factors by examining the characteristics of 87 autistic children and their families and deepening parents' perspectives and experiences of the 6- month CBD-rich cannabis treatment's benefits and barriers. Results: We found this treatment to have a high (75%) adherence rate, relatively mild side effects, and substantial reported benefits for the children and families. However, this treatment was not free of barriers; the intake regime, some side effects, and in some cases, unrealistic parental expectations made adherence difficult for some families. Conclusion: Our results highlight the importance of providing professional guidance and knowledge to parents of autistic children, enhancing their understanding of the impact of CBD-rich cannabis treatment on their children and expected related challenges, and coordinating realistic treatment expectations. We hope that addressing these important aspects will influence parents' ability to adhere to and enjoy the benefits of cannabis treatment for their autistic children.
KW - Adherence
KW - Autism spectrum disorder
KW - Children
KW - Family
KW - Medical cannabis
UR - http://www.scopus.com/inward/record.url?scp=85194109654&partnerID=8YFLogxK
U2 - 10.1159/000538901
DO - 10.1159/000538901
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 39015610
AN - SCOPUS:85194109654
SN - 2504-3889
VL - 7
SP - 68
EP - 79
JO - Medical Cannabis and Cannabinoids
JF - Medical Cannabis and Cannabinoids
IS - 1
M1 - 538901
ER -